The conversation between human and AI assistant.
How do physicians decide whether to subscribe a new drug/therapy when the expected benefit is unclear and still no HTA-assessment available?
What happens if there is conflicting or inconsistent evidence about the effectiveness of a new drug or therapy?
If there is conflicting or inconsistent evidence about the effectiveness of a new drug or therapy, physicians will often take a cautious approach and try to gather more information about the treatment before making a final decision. They might consult with other experts in the field, or they might wait for more research to be conducted before coming to a conclusion.